Literature DB >> 13081480

The problem of synergism and antagonism of combined drugs.

S LOEWE.   

Abstract

Keywords:  DRUGS

Mesh：

Substances：

Year:  1953        PMID： 13081480

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN： 0004-4172


× No keyword cloud information.
  289 in total

1.  Interaction of drugs: a methematical model and its application in bacteriology.

Authors:  O Calabi
Journal:  Experientia       Date:  1975-04-15

2.  A model-based approach for assessing in vivo combination therapy interactions.

Authors:  A M Lopez; M D Pegram; D J Slamon; E M Landaw
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

3.  Bactericidal activity of combinations of gentamicin with penicillin or clindamycin against Streptococcus mutans.

Authors:  R J Snyder; C J Wilkowske; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

4.  Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.

Authors:  Yijun Zhang; James H Chapman; Asim Ulcay; Richard E Sutton
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

5.  In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.

Authors:  H Kita; H Matsuo; H Takanaga; J Kawakami; K Yamamoto; T Iga; M Naito; T Tsuruo; A Asanuma; K Yanagisawa; Y Sawada
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 6.  SEDATIVES, ANALGESICS, ANTIDOTES, AND THEIR INTERACTION: A REVIEW.

Authors:  A B DOBKIN
Journal:  Can Anaesth Soc J       Date:  1964-05

7.  [Enhancement of therapeutic effects through combining of antibiotics].

Authors:  C VAN MARWYCK
Journal:  Z Hyg Infektionskr       Date:  1958

Review 8.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

9.  Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.

Authors:  G Nocentini; A Barzi; P Franchetti
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

10.  The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells.

Authors:  Cory T Zumbar; Aisulu Usubalieva; Paul D King; Xiaohui Li; Caroline S Mifsud; Hailey M Dalton; Muge Sak; Sara Urio; William M Bryant; Joseph P McElroy; George Farmer; Norman L Lehman
Journal:  J Neurooncol       Date:  2018-02-02       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.